Vyriad Competitors and Similar CompaniesClear all

Vyriad's competitors and similar companies include DNAtriX, ALX Oncology and Seagen.
Vyriad
Vyriad
Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer.
DNAtriX
DNAtriX
DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.
ALX Oncology
ALX Oncology
ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.
Seagen
Seagen
Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.
Founding Date
Founding Date
2016
Founding Date
2005
Founding Date
2015
Founding Date
1998
Type
Type
Private
Type
Private
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Rochester, US HQ
Locations
Houston, US HQ
San Diego, US
Locations
Burlingame, US HQ
Dublin 2, IE
Locations
Bothell, US HQ
Mississauga, CA
Hørsholm, DK
Rueil Malmaison, FR
München, DE
Milano, IT
Schiphol, NL
see more
Employees
Employees
49
Employees
3
Employees
743% increase
Employees
3,25622% increase

Financial

Net income
Net income
N/A
Net income
N/A
Net income
($101.7m) (FY, 2025)
Net income
($610.3m) (FY, 2022)

Funding

Latest funding round
Latest funding round
$ 24.4m (over 6 years ago)
Latest funding round
$ 15.5m (over 7 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 24.4m
Total funding raised
$ 54.2m
Total funding raised
$ 166m
Total funding raised
$ 164m
For sources of this data, please see the company profile

View Company Profiles

DNAtriX
HQ
Houston, US
Employees
3

DNAtrix is a biotechnology company that provides virus-driven immunotherapies for cancer.

View company
ALX Oncology
HQ
Burlingame, US
Employees
74↑ 3% increase

ALX Oncology is a company that develops protein-based therapeutics intended to help in cancer treatment.

View company
Seagen
HQ
Bothell, US

Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer.

View company